Elite members get real-time data, technical charting, alerts, and no ads - starting at $24.96/mo.
Try Elite for Free
Last Close
35.73
Oct 20 • 3:59 PM ET Dollar change+0.89 Percentage change(2.55%)
Aftermarket Close
35.73
Aftermarket • 7:30 PM ET Dollar change0.00 Percentage change(0.00%)
Index
RUT
Market Cap
1.57B
Enterprise Value
1.29B
Income
-122.90M
Sales
613.81M
Book/sh
34.51
Cash/sh
7.49
Employees
3000
IPO
Feb 02, 1995
P/E
-
Forward P/E
68.38
PEG
5.46
P/S
2.55
P/B
1.04
P/C
4.77
P/FCF
158.43
EV/EBITDA
32.35
EV/Sales
2.10
Quick Ratio
2.21
Current Ratio
2.50
Debt/Eq
0.04
LT Debt/Eq
0.04
Option/Short
Yes / Yes
EPS (ttm)
-2.67
EPS next Y
0.52
EPS next Q
0.12
EPS this Y
-36.00%
EPS next Y
60.09%
EPS next 5Y
12.53%
EPS past 3/5Y
40.29% -
Sales past 3/5Y
2.25% 8.85%
EPS Y/Y TTM
-9.38%
Sales Y/Y TTM
1.47%
EPS Q/Q
104.70%
Sales Q/Q
11.97%
Insider Own
1.57%
Insider Trans
1.53%
Inst Own
115.79%
Inst Trans
-6.14%
ROA
-5.75%
ROE
-7.04%
ROIC
-7.86%
Gross Margin
44.05%
Oper. Margin
-2.57%
Profit Margin
-20.02%
SMA20
-1.39%
SMA50
4.18%
SMA200
26.07%
Trades
Shs Outstand
43.76M
Shs Float
43.12M
52W High
46.41 -23.01%
52W Low
15.93 124.29%
Volatility
6.68% 6.48%
ATR (14)
2.18
RSI (14)
51.06
Beta
1.49
Rel Volume
0.83
Avg Volume
918.26K
Volume
760,416
Perf Week
-5.65%
Perf Month
5.87%
Perf Quarter
31.55%
Perf Half Y
35.96%
Perf YTD
7.43%
Perf Year
13.18%
Perf 3Y
-27.98%
Perf 5Y
-66.42%
Perf 10Y
172.75%
Prev Close
34.84
Price
35.73
Change %
2.55%
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Starr EphraimSVP, Gen Counsel & SecretaryJul 31 '26Buy24.173358,09668,728Aug 04 06:11 PM
Cornog William LDirectorMay 18 '26Buy16.3810,000163,80019,703May 19 04:10 PM
Azenta, Inc. is a global provider of life sciences solutions, enabling organizations worldwide to bring impactful breakthroughs and therapies to market faster. The company offers a suite of reliable cold-chain sample management solutions and multiomics services supporting drug development, clinical research, and advanced cell therapies for pharmaceutical, biotechnology, academic, and healthcare institutions globally. It operates through the following segments: Sample Management Solutions and Multiomics. The Sample Management Solutions segment provides end-to-end sample management products and services, including Sample Repository Services (SRS). Its core products include automated stores, cryogenic systems, automated sample tubes, consumables and instruments, and controlled-rate thawing devices. The Multiomics segment delivers genomic and other sample analysis services, including gene sequencing, gene synthesis, and related services. The company was founded in 1978 and is headquartered in Burlington, MA.
Ph.D.Dr. Martin D. Madaus D.V.M.
Executive VP & CFOMr. Lawrence Y. Lin
Senior VPMr. Ephraim Starr
Senior VP & Chief HR OfficerMs. Olga Pirogova
AdvisorDr. Ginger Zhou Ph.D.